If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humulin® R (U-100) (regular insulin human injection, USP [rDNA origin])100 units/mL
Humulin® R (U-500) (regular U-500 [concentrated] insulin human injection, USP [rDNA origin])500 units/mL
Humulin® 70/30 (70% human insulin isophane suspension and 30% human insulin injection [rDNA origin])100 units/mL
Humulin® N U-100 (human insulin [rDNA origin] isophane suspension)100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMULIN® (insulin human): Use With COVID-19 Vaccinations
Use of COVID-19 Vaccines in Patients Receiving Insulin Human
The safety and efficacy of insulin human used in patients who have received a COVID-19 vaccine have not been studied by Eli Lilly and Company. Please talk to your health care provider about whether you should get a COVID-19 vaccine.
For additional questions regarding your treatment with insulin human and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.
Date of Last Review: January 25, 2021